Sep 08, 2015
Japan-UK Regenerative Medicine Research Symposium
On 8th September 2015, the Embassy of Japan in the UK held the Japan-UK Regenerative Medicine Research Symposium 2015, a seminar focusing on the latest trends, regulatory environment and Japan-UK collaboration in the field of regenerative medicine. The Symposium was co-hosted by the Japan External Trade Organisation (JETRO), the Cell Therapy Catapult, and the ‘Find A Better Way’ charity.
Thanks to recent progress of iPS cells led by regenerative medicine research, there is now increasing worldwide optimism surrounding the development of new treatments for previously incurable diseases and injuries. Both in Japan and the UK, efforts towards achieving this are gathering pace, with a number of government, industry and charity initiatives. This event was held in the hope of further developing Japan-UK cooperation in the field of regenerative medicine, and featured presentations from leading figures in industry, government and academia of the two countries, along with discussion regarding how our two countries can work together in the future. The event was also honoured to welcome Sir Bobby Charlton, Founder of the ‘Find A Better Way’ charity.
More than 100 participants attended the event, including representatives from universities, charities and regulatory authorities. During the informative presentations, the latest regenerative therapy for heart disease using cell sheets was highlighted, and there were lively discussions regarding the latest trends in Japan and the UK, including the conditional approval system.
The success of the event proved that regenerative medicine was a ‘hot topic’ both in Japan and the UK, and highlighted the importance of further collaboration between our two countries in this field. A networking reception followed, where participants were able to enjoy Japanese food and drink.
14:15– 14:25 Opening remarks – Ambassador Keiichi Hayashi, Embassy of Japan in the UK
Session 1 - Latest trends and future of regenerative medicine research in Japan and the UK
14:25-14:45 Mr. Yutaka Hishiyama, Senior Director, Japan Agency for Medical Research and Development (AMED)
“Research and Development Policy on Regenerative Medicine in Japan”
14:45-15:05 Professor Yoshiki Sawa, Department of Cardiovascular Surgery, Osaka University
“Impact of regenerative therapy in Japan”
15:05-15:20 Dr. Jean-Philippe St-Pierre, Faculty of Engineering, Department of Materials Imperial College London
“Bio-inspired materials for applications in musculoskeletal repair”
15:20-15:35 Professor Paul A Townsend, Associate Dean & Theme Lead for Personalised Therapy, University of Manchester
“Regenerative Medicine in Manchester”
15:35-15:50 Dr. Davide Danovi, Director, HipSci Cell Phenotyping, Centre for Stem Cells and Regenerative Medicine, King’s College London
“Stem cells and their neighbourhoods: examples of translational research at CSCRM”
Dr. Setsuko Hashimoto, President & CEO, CellSeed Inc.
“Clinical Development of Regenerative Medicine Products Based on Cell Sheet Engineering Technology in Japan and Europe”
Dr. Hardy TS Kagimoto, President & CEO, Healios K.K.
“World first clinical research using iPS cell and its path for global approval”
16:15-16:30 Professor Johan Hyllner, Chief Scientific Officer, the Cell Therapy Catapult
“The Cell Therapy Catapult: Achievements and direction of travel”
Session 2 - Efforts towards innovation from regulatory authorities in Japan and the UK
16:55-17:15 Dr. Daisaku Sato, director Office of Cellular and Tissue based products , Japan -Pharmaceutical and Medical Devices Agency (PMDA)
“Regulatory Trends in Regenerative Medicine in Japan”
17:15-17:35 Mr. Ian Rees, GMP Expert Inspector, UK - Medicines and Healthcare Products Regulatory Agency (MHRA)
“MHRA support for innovation in healthcare products - the journey so far”
17:35-18:00 Efforts towards innovation in Japan and the UK, and future investment
18:00-18:10 Mr. Steve McGill CBE, “Find A Better Way”
18:10 - Networking Reception